Novel antibodies against RCD-8 as a tool to study processing bodies

Volumn 24, Issue 6, 2010, Pages 512-516

  Gudkova, D O ^a,b   Panasyuk, G G ^a   Nemazanyy, I O ^a   Filonenko, V V ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV   (Ukraine)

Author keywords

Decapping; Immunocytochemistry; MRNA processing; Processing bodies

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; POLYCLONAL ANTIBODY;

ARTICLE; CELL STRAIN HEK293; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; RNA DEGRADATION; RNA PROCESSING; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

MAMMALIA;

EID: 78650819865     PISSN: None     EISSN: None     Source Type: None    
DOI: 10.7124/bc.00017C     Document Type: Article

References (17)

1. Coller J., Parker R. Eukaryotic mRNA decapping. Annu. Rev. Biochem. 2004. 73. P. 861-890.
2. Cougot N., van Dijk E., Babajko S., Seraphin B. «Cap-ta-bolism». Trends Biochem. Sci. 2004. 29, N 8. P. 436-444.
3. Buchan J.R, Parker R. Eukaryotic stress granules: the ins and outs of translation. Mol. Cell. 2009. 36, N 6. P. 932-941.
4. Wilusz C., Wormington M., Peltz S. The cap-to-tail guide to mRNA turnover. Nat. Revs Mol. Cell Biol. 2001. 2, N 4. P. 237-246.
5. Averous J., Proud C. G. When translation meets transformation: the mTOR story. Oncogene. 2006. 25, N 48. P. 6423-6435.
6. Liu L., Li F., Cardelli J. A., Martin K. A., Blenis J., Huang S. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP pathways. Oncogene. 2006. 25, N 53. P. 7029-7070.
7. Sun S., Rosenberg L. M., Wang X., Zhou Z., Yue P., Fu H., Khuri F. R. Activation of akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Cancer Res. 2005. 65, N 16. P. 7052-7058.
8. Stinton L. M., Eystathioy T., Selak S., Chan E. K., Fritzler M. J. Autoantibodies to protein transport and messenger RNA processing pathways: endosomes, lysosomes, Golgi complex, proteasomes, assemblyosomes, exosomes, and GW bodies. Clin. Immunol. 2004. 110, N 1. P. 30-44.
9. Parker R., Sheth U. P bodies and the control of mRNA translation and degradation. Mol. Cell. 2007. 25, N 5. P. 635-646.
10. Garcia-Lozano J. R., Gonzales-Escribano M. F., Wichmann I., Nunez-Roldan A. Cytoplasmic detection of a novel protein containing a nuclear localization sequence by human autoantibodies. Clin. Exp. Immunol. 1997. 107, N 3. P. 501-506.
11. Yu J. H., Yang W. H., Gulich T., Bloch K. D., Bloch D. Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body. RNA. 2005. 11, N 12. P. 1795-1802.
12. Bloch D. B., Gulick T., Bloch K. D., Yang W. H. Processing body autoantibodies reconsidered. RNA. 2006. 12, N 5. P. 707-709.
13. Fenger-Gron M., Fillman C., Norrild B., Lykke-Andersen J. Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping. Mol. Cell. 2005. 20, N 6. P. 905-915.
14. Nemazanyy I., Breus O., Gout I., Filonenko V., Panasyuk G. Generation and characterization of monoclonal antibodies to mTOR kinase. Hybridoma. 2008. 27, N 5. P. 395-399.
15. Wilczynska A., Aigueperse C., Kress M., Dautry F., Weil D. The translational regulator CPEB1 provides a link between dcp1 bodies and stress granules. J. Cell Sci. 2005. 118, N 5. P. 981-992.
16. Mollet S., Cougot N., Wilczynska A., Dautry F., Kress M., Bertrand E., Weil D. Translationally repressed mRNA transiently cycles through stress granules during stress. Mol. Biol. Cell. 2008. 19, N 10. P. 4469-4479.
17. Cavigelli M., Li W., Lin A., Su B., Yoshioka K., Karin M. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. The EMBO J. 1996. 15, N 22. P. 6269-6279.